Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCE | Q02156 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | MYLK | Q15746 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | PRKCG | P05129 | 1/20 | 0.46 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | SHBG | P04278 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 4/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1738342 | 0.79 | SHBG (0.39) | TDP1ALDH1A1SHBGGAACYP3A4 | |
| SCHEMBL13623354 | 0.79 | SHBG (0.59) | TDP1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL10070498 | 0.79 | PRKCE (0.48) | PRKCETDP1MYLKMEN1ALDH1A1 | |
| SCHEMBL16854091 | 0.78 | SHBG (0.52) | PRKCETDP1MYLKMEN1ALDH1A1 | |
| SCHEMBL13090303 | 0.76 | SHBG (0.66) | PRKCETDP1MYLKMEN1ALDH1A1 | |
| SCHEMBL30416054 | 0.76 | SHBG (0.66) | PRKCETDP1MYLKMEN1ALDH1A1 | |
| SCHEMBL49544 | 0.75 | CA1 (0.58) | TDP1MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL3356238 | 0.74 | ALOX15 (0.47) | PRKCETDP1MYLKMEN1ALDH1A1 | |
| SCHEMBL14642588 | 0.74 | PRKCE (0.44) | PRKCETDP1MYLKMEN1ALDH1A1 | |
| SCHEMBL23638591 | 0.74 | HPGD (0.42) | MEN1ALDH1A1MAPTKMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090291990-A1 | OXADIAZOLYL-PHENOXYALKYLISOXAZOLES, COMPOSITIONS THEREOF AND METHODS FOR THEIR USE AS ANTI-PICORNAVIRAL AGENTS | RHODES GERALD | 2009-11-26 | — | — | US | disclosed |
| US-7585884-B2 | Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents | VIROPHARMA INCORPORATED (US) | 2009-09-08 | — | — | US | disclosed |
| US-20080293783-A1 | OXADIAZOLYL-PHENOXYALKYLISOXAZOLES, COMPOSITIONS THEREOF AND METHODS FOR THEIR USE AS ANTI-PICORNAVIRAL AGENTS | VIROPHARMA INCORPORATED | 2008-11-27 | — | — | US | disclosed |
| US-7429606-B2 | Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents | VIROPHARMA INCORPORATED (US) | 2008-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293783-A1 | OXADIAZOLYL-PHENOXYALKYLISOXAZOLES, COMPOSITIONS THEREOF AND METHODS FOR THEIR USE AS ANTI-PICORNAVIRAL AGENTS | PLEC, CPSF7, CPSF1 | PRKCE 4293/4885TDP1 1055/4885MYLK 2528/4885 |
| US-20090291990-A1 | OXADIAZOLYL-PHENOXYALKYLISOXAZOLES, COMPOSITIONS THEREOF AND METHODS FOR THEIR USE AS ANTI-PICORNAVIRAL AGENTS | PLEC, CPSF7, CPSF1 | PRKCE 4293/4885TDP1 1055/4885MYLK 2528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.